氨酸触发了库尼斯综合征:病理生理学和临床见解
Cesare de Gregorio1, Lucio Granata1, Davide Raspanti1
1Department of Clinical and Experimental Medicine, Cardiology Unit, Heart Failure Outpatient Laboratory, University Hospital of Messina, Messina, Italy.
International journal of cardiology
|April 12, 2025
概括
塞夫特里亚触发的库尼斯综合征 (CTKS) 是一种罕见的疾病,由于过敏引起的急性冠状动脉综合征. 大多数病例涉及冠状动脉,通常以良好的结果解决.
科学领域:
- 心脏病学 心脏病学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 库尼斯综合征 (KS) 是一种急性冠状动脉综合征 (ACS),由对各种过敏原的过敏反应引发.
- 类素,特别是 ceftriaxone,经常与药物诱导的 KS 有关.
- 本研究的重点是triaxone触发的KS (CTKS) 的临床特征.
研究的目的:
- 研究患有CTKS的患者的临床特征和结果.
- 分析CTKS的呈现和致病机制.
主要方法:
- 对截至2024年12月发表的CTKS病例进行了全面的文献审查.
- 分析了已识别的CTKS患者的医疗记录.
- 另外还包括了一例涉及无意中使用双重塞夫特里亚的病例.
主要成果:
- 分析了10名CTKS患者 (平均年龄61岁,5名男性).
- 第一种类型的KS (冠心血管) 发生在80%的病例中;第二种类型的KS (斑块血栓症) 发生在20%的病例中.
- 右冠状动脉是最常受到影响的血管;所有患者在出院后都有良好的临床结果.
结论:
- CTKS是一种罕见但潜在的未被认可的临床实体.
- 它可以发生在没有过敏或冠状动脉疾病病史的人身上.
- 主要的I型变体表明冠状动脉血管是主要的机制.
相关概念视频
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Cytotoxic T Cells-mediated Immune Response
736
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
736


